home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
   
 

news archive genetic news - February 6, 2006

 
  February 6, 2006
your information resource in human molecular genetics
 
     
- Dosing convenience mandates the pipeline of glucagon-like peptide-1 (GLP-1) analogs for type 2 diabetes
Twice-daily injection is the benchmark set by exenatide, the first GLP-1 analog launched in the US by Lilly in June 2005 and half-year sales of US$ 74.6 mln, which now faces competition by GLP-1 analog treatment modalities with less frequent dosing.
- Association between schizophrenia and the DISC1 gene
Polymorphisms increase risk of schizophrenia in Scottish population sample

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.